Anuh Pharma Files 66th Annual Report for FY26

Anuh Pharma Ltd has submitted its 66th Annual Report for the Financial Year 2025-26, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, available on the company's website, details the company's performance and strategic initiatives under the theme 'Foundations for the Future: Building Capacity. Enabling Growth.' The report includes a 10-year financial summary, highlighting key metrics such as Share Capital, Reserves, Borrowings, Gross Block, and Net Block. It also presents the Revenue Account, showing Total Revenue, EBITDA, Profit Before Tax, Profit After Tax, and Earnings Per Share over the past decade. The company also announced a recommended final dividend of ₹1.50 per equity share.